License U of T Technologies

Who is this for?

Industry and other parties interested in licensing or otherwise using University of Toronto (U of T) technologies.

What do I need before I can begin?

There is no information required to begin. Please reach out to the Director, Innovations at 416-946-5515 if you have questions regarding licensing or using U of T technologies.

Licensing & Technology Opportunities

U of T is a global leader in turning research into products, services, companies and jobs. The Innovations & Partnerships Office (IPO) is your one-stop-shop to license these technologies and innovations from U of T. IPO’s team of licensing professionals make the process as quick and easy as possible.

Use our technology explorer to discover our startups, market-ready innovations, and licensing opportunities, or, contact us to discuss custom solutions.
 

Title Tech Opps Keywords
Human Culture Assay to Assess Muscle Stem Cell Potency Regenerative Medicine , stem cells , Stem cell-mediated repair , Muscular Dystrophy , Cell Therapy 
Novel Substrates for Chemically Defined Culture of Human Pluripotent Stem Cells stem cell culture , pluripotent , Regenerative Medicine , stem cells , tissue culture reagents , Biomaterials 
ODAIA: AI-Driven Customer Journey Intelligence Data Analytics , Artificial Intelligence (AI) , Software , Companies , Research Tools 
Novel Counter-Measure Against Nerve Gas & Other Organophosphate/Carbamate Poisoning Advanced Health Technologies , Drug Discovery , Health & Related Life Sciences , molecular mechanisms , Pharmaceutical Research / Manufacturing , Pharmaceuticals , Small Molecules 
Cyber-resilient protection for energy grids Energy , Cybersecurity , Smart Cities 
CrossShade: Automated 3D shading from sketches Computer Graphics , Animation , 3D imaging , Software 
Automatic Learning Filters to Improve the Accuracy of Sensing Algorithms Artificial Intelligence (AI) , Machine Learning , Data Analytics , Neural Networks , Wearable Tech , Software 
Targeting the Hippo Pathway for Cancer & Fibrosis Advanced Health Technologies , Biotechnology , Cancer , Cell Signaling , Drug Discovery , Health & Related Life Sciences , Inflammation , Pharmaceuticals , Small Molecules , Therapeutics 
Inhibition of PKN1 As Therapy For Chronic Lymphocytic Leukemia (CLL) Advanced Health Technologies , Biotechnology , Cancer , Drug Discovery , Health & Related Life Sciences , Leukemia , Pharmaceuticals , Small Molecules , Therapeutics 
Re-PAIR: A CRISPR-Based Technology for Portable Diagnostics & Biotechnology CRISPR , Portable  , Diagnostics , Biotechnology , Biosensor , Cell-Free System , Nucleic Acid 

VPRI Role

  • Market U of T technologies to industry
  • Negotiate license agreements with interested companies
  • Assist in finding partners and funding to support proof-of-concept and commercialization
  • Support long-term relationships with strategic partners that help develop early-stage discoveries into market-ready technologies and products

VPRI Contact

Staff

Jennifer Fraser

Director, Innovations
Innovations & Partnerships Office (IPO)
(416) 946-5515
Radio Options- Did you find this useful?
Did you find this useful?
Let us know if you found this page useful. Did you find the information you were looking for?